| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2011 | EP2308511A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 04/13/2011 | EP2308510A1 Agent for regeneration and/or protection of nerves |
| 04/13/2011 | EP2308509A1 Inhibitor of analgesic tolerance |
| 04/13/2011 | EP2308507A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
| 04/13/2011 | EP2308497A1 Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers |
| 04/13/2011 | EP2308496A2 Formulation containing phosphate derivatives of electron transfer agents |
| 04/13/2011 | EP2308495A1 Method and composition for treating peripheral vascular diseases |
| 04/13/2011 | EP2308494A1 Tamper resistant dosage forms |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308492A1 Process for preparing lansoprazole |
| 04/13/2011 | EP2308491A1 Pirfenidone therapy and inducers of cytochrome P450 |
| 04/13/2011 | EP2308490A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 04/13/2011 | EP2308489A1 Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock |
| 04/13/2011 | EP2308488A1 Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death |
| 04/13/2011 | EP2308487A1 An entacapone-containing oral dosage form |
| 04/13/2011 | EP2308486A1 Pufa supplements |
| 04/13/2011 | EP2308485A1 Sulfonamides for the prevention of diabetes |
| 04/13/2011 | EP2308484A1 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| 04/13/2011 | EP2308483A1 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 04/13/2011 | EP2308482A1 Novel use of peptide compounds for treating muscle pain |
| 04/13/2011 | EP2308481A1 Combination therapy for the treatment of hypertension |
| 04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
| 04/13/2011 | EP2308478A1 Delivery system for sustained release of a calcium-channel blocking agent |
| 04/13/2011 | EP2308477A1 Delayed release rasagiline formulation |
| 04/13/2011 | EP2308476A1 Colonic purgative composition with soluble binding agent |
| 04/13/2011 | EP2308475A1 Matrix for sustained, invariant and independent release of active compounds |
| 04/13/2011 | EP2308474A1 Matrix for sustained, invariant and independent release of active compounds |
| 04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
| 04/13/2011 | EP2308472A1 Pharmaceutical compositions comprising rivaroxaban |
| 04/13/2011 | EP2308470A1 Sustained-release liposomal anesthetic compositions |
| 04/13/2011 | EP2308468A1 Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
| 04/13/2011 | EP2308467A2 Liquid pharmaceutical formulations of docetaxel |
| 04/13/2011 | EP2308466A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 04/13/2011 | EP2308464A1 Orally disintegrating compositions of pramipexole |
| 04/13/2011 | EP2308463A1 Aqueous acetaminophen compositions and method of preparation |
| 04/13/2011 | EP2308456A1 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 04/13/2011 | EP2308431A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 04/13/2011 | EP2308430A2 Method and manufacture of a wound dressing for covering an open wound |
| 04/13/2011 | EP2308320A2 Hydroxypropylated starch for preventing/treating diabetes |
| 04/13/2011 | EP2307439A1 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 04/13/2011 | EP2307438A2 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 04/13/2011 | EP2307435A1 Salts of hiv inhibitor compounds |
| 04/13/2011 | EP2307434A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 04/13/2011 | EP2307432A1 A digoxin-like fungal glycoside with cytotoxic properties: novel assay and applications |
| 04/13/2011 | EP2307426A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 04/13/2011 | EP2307425A1 Imidazothiadiazoles derivatives |
| 04/13/2011 | EP2307423A1 Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids |
| 04/13/2011 | EP2307422A1 Novel spirochromanone carboxylic acids |
| 04/13/2011 | EP2307421A1 Oxindole compounds |
| 04/13/2011 | EP2307420A1 Nalmefene di-ester prodrugs |
| 04/13/2011 | EP2307418A1 Novel phenylimidazopyrazines |
| 04/13/2011 | EP2307417A2 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds |
| 04/13/2011 | EP2307416A2 Substituted tricyclic derivatives against neurodegenerative diseases |
| 04/13/2011 | EP2307415A1 New trinem antibiotics and inhibitors of beta-lactamases |
| 04/13/2011 | EP2307414A2 Pi3k isoform selective inhibitors |
| 04/13/2011 | EP2307413A1 Novel phenyl-imidazopyridines and pyridazines |
| 04/13/2011 | EP2307412A2 Heterocyclic derivatives as modulators of ion channels |
| 04/13/2011 | EP2307411A1 Triazolopyridine compounds useful as kinase inhibitors |
| 04/13/2011 | EP2307410A1 Aza-beta-carbolines and methods of using same |
| 04/13/2011 | EP2307409A1 Pyrrolopyridines as kinase inhibitors |
| 04/13/2011 | EP2307408A1 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 04/13/2011 | EP2307407A2 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 04/13/2011 | EP2307405A1 Composition of flavanolignan and amino acid with improved water solubility |
| 04/13/2011 | EP2307402A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors |
| 04/13/2011 | EP2307401A2 Antineoplastic derivatives of 4-oxo-1,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 04/13/2011 | EP2307400A2 Inhibitors of pi3 kinase |
| 04/13/2011 | EP2307397A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 04/13/2011 | EP2307396A1 Renin inhibitors and method of use thereof |
| 04/13/2011 | EP2307394A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 04/13/2011 | EP2307389A1 Dibenzothiazepine derivatives and use thereof |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307385A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 04/13/2011 | EP2307383A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307382A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307380A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/13/2011 | EP2307379A2 Organic compounds |
| 04/13/2011 | EP2307378A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307377A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307376A1 Novel phenylamino isonicotinamide compounds |
| 04/13/2011 | EP2307375A1 Phenanthrenone compounds, compositions and methods |
| 04/13/2011 | EP2307374A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 04/13/2011 | EP2307372A1 Heterocyclic antiviral compounds |
| 04/13/2011 | EP2307371A2 Organic compounds |
| 04/13/2011 | EP2307367A2 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 04/13/2011 | EP2307364A1 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 04/13/2011 | EP2307363A1 Piperidyl acrylamide antogonists of ccr2 |
| 04/13/2011 | EP2307362A2 Antagonists of prostaglandin d2 receptors |
| 04/13/2011 | EP2307357A1 L-menthyl-n-(2-hydroxyphenyl)carbamate |
| 04/13/2011 | EP2307354A1 Process for preparing a benzoylbenzeneacetamide derivative |
| 04/13/2011 | EP2307351A2 Novel salts of (4-{ý(5-{ý(3-chlorophenyl)methyl¨oxy}-2-methylphenyl)carbonyl¨amino}-3-methylphenyl)acetic acid |
| 04/13/2011 | EP2307344A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 04/13/2011 | EP2307342A1 Diglycidic ether derivative therapeutics and methods for their use |
| 04/13/2011 | EP2307056A2 Stabilized aqueous formulation containing paracetamol |
| 04/13/2011 | EP2307052A2 Anti-beta-2-microglobulin agents and the use thereof |
| 04/13/2011 | EP2307032A2 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 04/13/2011 | EP2307031A1 Film-forming liquid formulations for drug release to hair and scalp |
| 04/13/2011 | EP2307030A1 Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 04/13/2011 | EP2307029A1 Rna antagonists targeting hsp27 |
| 04/13/2011 | EP2307028A1 Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy |